Protective Immune Responses Generated in Animal Models GAITHERSBURG, Md., Dec. 6, 2010 /PRNewswire-FirstCall/ — GenVec, Inc. (Nasdaq: GNVC) announced today that data were presented on GenVec’s respiratory syncytial virus (RSV) vaccine program at…
Continued here:
Promising Data Presented on GenVec RSV Program